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Abstract
Background: Although heart transplantation is a successful therapy for patients suffering from end-stage heart
failure, the therapeutic is limited by the lack of organs. Donor cardiac arrest is a classic hindrance to heart retrieval
as it raises issues on post-transplant outcomes.
Case presentation: The present case reports a successful heart transplantation after prolonged donor cardiac arrest
(total lowflow time of 95 minutes) due to anaphylactic shock necessitating extracorporeal life support. We further
provide an overview of the current evidence and outcomes of heart transplantation in cases of donor cardiac arrest.
Conclusion: Providing that donor and recipient criteria are respected, donor cardiac arrest does not seem to be an
adverse predictor in heart transplantation.
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Background
Heart transplantation is an effective therapy for patients
suffering from end-stage heart failure, but the procedure
is limited by the shortfall in the availability of organs. Al-
though demand is likely to continue to increase, the
number of heart transplantations has decreased in the
past decades [1] pushing the limits in exploring, evaluat-
ing and resuscitating “borderline” donor organs. In spe-
cific settings, even hearts with suboptimal function may
be transplanted with similar mortality rates than those
with normal function [2].
Case presentation
A 17-year-old female with a history of allergy and sys-
temic reactions to peanuts unknowingly ate a plate of
Spaghetti in a Chinese restaurant cooked with ground-
nut oil. She immediately developed an anaphylactic
shock with dyspnea, agitation and cardiac arrest. Cardio-
pulmonary resuscitation (CPR) was begun upon arrival
of the medical emergency team, 10 minutes after
collapse-the first rhythm was asystole. Intravenous Epi-
nephrine (total dose 10 mg) and fluid administration
(total 2.5 L) were administered and although transient
return to spontaneous circulation was achieved at 22 mi-
nutes, the patient rearrested with recurrent pulseless
electrical activity and then asystole. Only mild laryngeal
edema was noted on intubation. She was transferred to
our tertiary care facility, under continuous CPR with the
Lund University Cardiac Arrest System–Version 2 device
(LUCAS 2; Jolife AB, Lund, Sweden). Immediate femoro-
femoral, veno-arterial extra-corporeal life support (ECLS)
was surgically implanted (RotaFlow, Maquet, Hirrlingen,
Germany). No-flow was estimated to be 10 minutes and
total low-flow from CPR initiation to full ECLS support
95 minutes. Soon after the establishment of the VA-
ECLS, the patient regained an effective sinus rhythm.
However, the transesophageal echocardiography per-
formed during the implantation procedure showed a bi-
lateral ventricular dysfunction with global hypokinesia
(Additional file 1). In order to maintain both a left ven-
tricular drainage and a mean arterial pressure (MAP)
above 65 mmHg, a hemodynamic support with dobuta-
mine and norepinephrine was necessary during the first
12 hours. There was no sedative or analgesic adminis-
tration at any point during pre- or in-hospital care.
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Clinically, the patient was deeply comatose-Glasgow
Coma Scale 3–with bilaterally dilated pupils unrespon-
sive to light. Complete clinical examination and brain
death assessment were performed according to the
guidelines of the Swiss Academy of Medical Sciences
[3]. The apnea test was carried out in accordance with
previously published data on apnea test and brain death
testing in patients under ECLS [4]. The clinical diagnosis
of brain death was established 16 h after hospital ad-
mission and the parents consented to organ donation.
Thyroid hormones, low dose corticosteroids and des-
mopressin were administered for the organ preserva-
tion and diabetes insipidus.
Cardiac assessment for heart donation was made by
transthoracic echocardiography (TTE). Given the young
age, coronary angiography was not performed. TTE dis-
played normal findings with no inotropic or vasoactive
support and ECMO flow lowered to 1.5 L / min (Add-
itional file 2). Left ventricular function was assessed by
measuring the left ventricular outflow tract velocity time-
integral (16 cm), visual assessment of the left ventricu-
lar ejection fraction (60 %) and measurement of the
systolic peak velocity of the mitral annulus (TDSa) (>
6 cm/s). Right ventricular function was assessed visually
and by tricuspid annular plane systolic excursion
(TAPSE) (18 mm). There were no segmental anomalies
as well as normal valves. The heart was retrieved 50 h
after hospital admission (total ECLS support of 50 h,
ECLS support prior to organ assessment 16 h and time
from assessment to transplant 34 h). Warm and cold is-
chemia times were 23 and 202 minutes respectively.
The heart was transplanted in an 11-year-old female
with anthracyclin-induced cardiomyopathy following
treatment for high-grade osteosarcoma of the tibia. The
immediate post-operative course was favourable allow-
ing extubation on day 2, she required milrinone but no
mechanical support for a total intensive care length of
stay of 21 days. The patient was discharged 56 days
post transplantation, she is symptom-free at 6-month
follow-up with normal cardiac function.
Discussion
Medical teams may be reluctant to heart retrieval from
resuscitated donor cardiac arrest due to concerns on
post-transplant outcomes. The critical question is if
these hearts can resist the ischemic injury of procure-
ment, storage and transportation.
The impact of donor cardiac arrest on heart transplant-
ation was studied in a retrospective cohort analysis of 19′
980 cardiac transplantations form the United Network for
Organ Sharing Registry [5]. The 856 cases with donor his-
tory of cardiac arrest (median duration of arrest time
15 min) had unadjusted 30-day, 1-, 5-and 10-year actuarial
survival rates similar to the non-arrest group. Patients
receiving hearts with short arrest duration (0–8 min)
had significantly improved survival rates as compared with
all other patients including those from the non-arrest
group. It was hypothesized that ischemic preconditioning
may explain this observation. However, an increase in the
duration of arrest time (> 25 min) was associated with de-
creased survival. Cardiac arrest did not negatively influ-
ence survival after heart transplantation in a cohort of 604
patients, 38 of which were transplanted with hearts from
donors who were resuscitated after a cardiac arrest of
mean duration of 15 min [6]. The one-and 5-year survival
comparing arrest and non-arrest groups was 94.2 % vs.
83.6 % and 79.8 % vs. 74.5 % respectively (p = 0.35). Donor
cardiac arrest was not an adverse predictor of mortality on
multivariate analysis.
Furthermore, a large multicentre transplant database
of the 29,242 adult heart transplantations in which
1,396 patients (4.7 %) received hearts from CPR donors
did not show inferior outcomes at 5-year follow-up in
recipients of heart transplantation from selected CPR
donors [7].
However, none of the patients in the above described
cohorts benefited from ECLS. The issue of extracorporeal
support and heart transplantation has been addressed in a
case series from Taiwan in which 5 donors after brain
death were put on ECLS due to acute hemodynamic in-
stability. Of these, 3 hearts were harvested with uneventful
outcomes in the recipients [8].
The management of endocrine dysfunction in potential
heart donation is of particular interest. The deterioration
of cardiac function and need for inotropic support could
be reversed by T3 supplementation. [9] A retrospective
analysis based on 63,593 donors showed that T3/T4
therapy results in more transplantable organs, with no
decrease in post transplantation graft survival [10].
Corticosteroid administration is associated with significant
reductions in early graft dysfunction in heart transplant-
ation [11] and desmopressin can improve the number and
quality of retrieved organs. [12]
Transthoracic echocardiography is the preferred im-
aging method for donor heart assessment [13]. It is para-
mount that patients under ECLS meet the qualitative and
quantitative echocardiographic weaning criteria [14]. We
believe that the positive outcome was not only due to the
respect of standard donor and recipient criteria but also
because of a careful selection process combining clinical
and echocardiographic assessment. The complete recov-
ery of the myocardium may have been due to the revers-
ible nature of the cause. Anaphylactic shock-associated
cardiomyopathy results in acute heart failure secondary to
severe coronary vasospasm and usually recovers quickly
without major sequelae [15, 16]. The initiation of ECLS
provided timely hemodynamic support and may well have
speeded coronary perfusion optimisation and left
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ventricular function recovery. The satisfactory TTE find-
ings and the young age of the patient, prompted consider-
ation for organ donation.
To date, there is minimal data on ECLS in donor car-
diac arrest and heart transplantation. The use of ECLS
in the present case was for the sole attempt of saving the
patient and the unfortunate cerebral insult that ensued
shifted the goals towards optimisation of potentially trans-
plantable organs. The question of ECLS in heart donation
after cardiac arrest is complex and raises both technical
(timely cannulation with exclusion of the cerebral circula-
tion) and major ethical issues (the donor ceases to be
“non-heart beating” once the coronary circulation is re-
stored). Whether or not this is a potential field for donor
heart expansion is uncertain. The cost effectiveness is of
course debatable and will vary between health systems.
Finally, the cause of cardiac arrest-the peanut allergy-
should not be overlooked as the allergy may be “trans-
mitted” to the recipient with major consequences [17].
Conclusion
Providing donor and recipient criteria are carefully
respected, heart transplantation may be successful even
after prolonged donor cardiac arrest.
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Additional file 1: Transesophageal echocardiography (transgastric
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